Showing 22,361 results

Filters Content type: Editors' picks
Combatting stigma

Anti-Stigma “I Can Give U” Campaign Takes Social Media by Storm

Editor's pick
TheBody
14 October 2020
Coronavirus

Kaletra Still Shows No Benefit for COVID-19

Editor's pick
POZ
14 October 2020
PrEP programmes & uptake

PrEP Uptake Defies COVID-19 in 2020

Editor's pick
AVAC
14 October 2020
Tuberculosis & HIV

WHO estimates 20% more TB cases in South Africa than previously thought

Editor's pick
Spotlight
14 October 2020
The search for a cure

Remembering Timothy Ray Brown: A Champion for HIV Cure Research

Editor's pick
National Institutes of Health
13 October 2020
Hepatitis C transmission & prevention

UK: Report indicates more investment in harm reduction needed to tackle hepatitis C

Editor's pick
Hepatitis C Trust
13 October 2020
Experiences of stigma

'Corona carriers': Stigma halts medication and meet-ups for HIV+ Malawians

Editor's pick
Thomson Reuters Foundation
13 October 2020
Quality of life

Over Half in UK HIV Women's Study Report Moderate or Severe Pain

Editor's pick
NATAP
13 October 2020
Cancer

Highest Cancer Risk in HIV+ Current Smokers and Those With Poor HIV Control

Editor's pick
NATAP
13 October 2020
Resistance

Multidrug Resistance Still Boosts Death Risk in 31,000-Person Italian Study

Editor's pick
NATAP
13 October 2020
Coronavirus

Indonesia: Seven months on, pandemic still threatens AIDS care

Editor's pick
Jakarta Post
13 October 2020
Diabetes

Can an HIV Drug Help Prevent Diabetes?

Editor's pick
American Journal of Managed Care
13 October 2020
People & personal stories

An open and honest account of living with HIV in 2020 - Matthew Hodson Interview

Editor's pick
YouTube
12 October 2020
Activism & civil society

Meet Michael Chancley, an Atlanta Resident Now Helming the PrEP Facts Facebook Group

Editor's pick
TheBody
11 October 2020
Quality of life

Is Being Undetectable Enough?

Editor's pick
POZ
11 October 2020
People with limited treatment options

Patients with HIV and four-class drug resistance have high disease burden

Editor's pick
Healio
11 October 2020
New & experimental HIV treatments

Capsid inhibitor lenacapavir, dosed six-monthly, has high barrier to drug resistance and no cross-resistance to other classes

Editor's pick
i-Base
9 October 2020
Neurological & cognitive problems

ART reduces Alzheimer's prevalence among patients with HIV

Editor's pick
Healio
9 October 2020
PrEP programmes & uptake

UK: Superdrug is now offering PrEP for the first time

Editor's pick
Gay Star News
9 October 2020
Ethnic & cultural minorities

U.S. Immigration and Customs Enforcement Raids Are Stopping Latinx Queer And Trans Men From Getting HIV Care

Editor's pick
Forbes
9 October 2020
Coronavirus

Australia: Resume PrEP, Urge Community Leaders

Editor's pick
Star Observer
9 October 2020
Coronavirus

BHIVA ‘2nd COVID peak’ guidance for HIV clinics - plain English version

Editor's pick
BHIVA
8 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Sex workers

Lessons from the Ashodaya PrEP project in India

Editor's pick
UNAIDS
7 October 2020